Latest Vagus nerve stimulation Stories
HOUSTON, Nov. 2 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced another in a series of collaborations around seizure detection technology aimed at advancing its development of new and more efficacious medical devices for persons suffering from epilepsy. On October 19, 2009, Cyberonics entered into two agreements with Flint Hills Scientific L.L.C., a world leader in real-time detection and quantification of epileptic seizures through cardiac signal detection and...
Researchers at Medical University of South Carolina (MUSC) pioneer bilateral epidural prefrontal cortical stimulationA new neurosurgical procedure may prove helpful for patients with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was found generally safe and provided significant improvement of depressive symptoms in a small group of patients, according to lead researcher Ziad Nahas, M.D. at the Medical University of South Carolina. The data are...
Researchers at Medical University of South Carolina (MUSC) pioneer bilateral epidural prefrontal cortical stimulation CHARLESTON, S.C., Oct. 13 /PRNewswire-USNewswire/ -- A new neurosurgical procedure may prove helpful for patients with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was found generally safe and provided significant improvement of depressive symptoms in a small group of patients, according to lead researcher Ziad Nahas, M.D. at the...
HOUSTON, Oct. 2 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced two collaborations in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy. On October 1, 2009, Cyberonics entered into a License Agreement with NeuroVista Corporation, providing Cyberonics with access to a range of technology and patents in exchange for payments extending through April 2011. The NeuroVista technology will enable Cyberonics to...
HOUSTON, Sept. 24 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Greg Browne, Chief Financial Officer, will present at the JMP Securities 4th Annual Healthcare Focus Conference in New York on Tuesday, October 6, 2009 at 3:30 PM EDT. JMP Securities will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/jmp9/cybx/. The replay will be available for 90 days following the conference. Presentation slides will be available...
HOUSTON, Sept. 17 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that James Reinstein, Cyberonics' Vice President, Sales & Marketing and General Manager, International, will present at the Maxim Group Growth Conference in New York on Tuesday, September 29, 2009 at 2:30 PM EDT. Maxim will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/maxim2/cybx/. The replay will be available for 90 days following the conference....
HOUSTON, Sept. 10 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 22, 2009 at 4:00 PM EDT. UBS will host a webcast of the presentation live and by replay at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=82_IT8KY1C. The replay will be available for 90 days following the...
HOUSTON, Aug. 6 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Greg Browne, Chief Financial Officer, will present at the Canaccord Adams 29th Annual Global Growth Conference in Boston on Thursday, August 13, 2009 at 10:00 AM EDT. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM EDT on Thursday, August 13, 2009. Canaccord Adams will host a webcast of the presentation live and by replay at...
HOUSTON, Aug. 4 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the first quarter ended July 24, 2009 of its fiscal year ending April 30, 2010 on Wednesday, August 19, 2009 at 5:00 PM EDT. The company will conduct a conference call to discuss those results on Thursday, August 20, 2009 at 9:00 AM EDT. Fiscal Year 2010 First Quarter Results Conference Call Instructions To listen to the conference call live by...
HOUSTON, July 24 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the U.S. Food and Drug Administration ("FDA") has approved the company's proposal to amend the protocol of its D-21 post-approval dosing study in depression patients treated with VNS Therapy(TM).The company submitted a proposal in November 2008 to reduce the number of study subjects from 460 to 330 and completed enrollment of 331 study subjects in February 2009. With this decision from the FDA,...
